Jon Mishkin
Chief Financial Officer
Jon is the Chief Financial Officer as well as an Executive Team Member at Symbio, a role he has held since March 2023. With over 20 years of experience in finance and accounting, he is responsible for overseeing Symbio’s global financial strategy and execution, including budgeting, forecasting, reporting, consolidations, and cash management.
Jon’s career spans leadership roles in financial management within the healthcare and pharmaceutical services industries. Prior to joining Symbio, he served as CFO at Theradex Systems Inc., a global oncology-focused Clinical Research Organization. Before that, he was CFO at Clinical Financial Services, where he led financial operations for a technology-enabled pharma services provider specializing in clinical trial business and financial management.
Earlier in his career, Jon held key financial leadership positions at Viasys Healthcare (acquired by Cardinal Health), including Controller, Asia Pacific, and Director, FP&A – Asia Pacific. Based in Hong Kong, he oversaw financial operations across the region, managing teams in Hong Kong, Beijing, and other Asia-Pacific markets.
Jon earned a B.S. in Finance from the Smeal College of Business at Pennsylvania State University (Penn State). He has deep expertise in finance and accounting, financial planning and analysis, international operations, mergers and acquisitions, and corporate consolidations.